IXHL Latest Press Releases

-- September 9, 2026 --

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position Globe Newswire 8:00 AM

-- August 25, 2026 --

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X Globe Newswire 8:46 AM

-- August 11, 2026 --

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 Globe Newswire 8:00 AM

-- July 23, 2026 --

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea Globe Newswire 8:00 AM

-- June 25, 2026 --

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea Globe Newswire 8:00 AM

-- June 10, 2026 --

Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility Globe Newswire 8:00 AM

-- June 9, 2026 --

Incannex Announces Initiation of Research Coverage by Alliance Global Partners Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes